|
1
|
Braet F and Wisse E: Structural and
functional aspects of liver sinusoidal endothelial cell fenestrae:
A review. Comp Hepatol. 1:12002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iwakiri Y and Groszmann RJ: Vascular
endothelial dysfunction in cirrhosis. J Hepatol. 46:927–934. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deleve LD, Wang X and Guo Y: Sinusoidal
endothelial cells prevent rat stellate cell activation and promote
reversion to quiescence. Hepatology. 48:920–930. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ling Y, Yang Y, Lu N, You QD, Wang S, Gao
Y, Chen Y and Guo QL: Endostar, a novel recombinant human
endostatin, exerts antiangiogenic effect via blocking VEGF-induced
tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Biochem
Biophys Res Commun. 361:79–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whitworth A: Endostatin: are we waiting
for Godot? J Natl Cancer Inst. 98:731–733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tong Y, Zhong K, Tian H, Gao X, Xu X, Yin
X and Yao W: Characterization of a monoPEG20000-Endostar. Int J
Biol Macromol. 46:331–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ni Q, Ji H, Zhao Z, Fan X and Xu C:
Endostar, a modified endostatin inhibits non small cell lung cancer
cell in vitro invasion through osteopontin-related mechanism. Eur J
Pharmacol. 614:1–6. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li XQ, Shang BY, Wang DC, Zhang SH, Wu SY
and Zhen YS: Endostar, a modifed recombinant human endostatin,
exhibits synergistic effects with dexamethasone on angiogenesis and
hepatoma growth. Cancer Lett. 301:212–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Liu DG, Yang G, Kong LJ, Du YJ,
Wang HY, Li FD, Pei FH, Song JT, Fan YJ, et al: Endostar, a novel
human recombinant endostatin, attenuates liver fibrosis in
CCl4-induced mice. Exp Biol Med (Maywood). 239:998–1006. 2014.
View Article : Google Scholar
|
|
10
|
Wang H, Zhang Y, Wang T, You H and Jia J:
N-methyl-4-isoleucine cyclosporine attenuates CCl-induced liver
fibrosis in rats by interacting with cyclophilin B and D. J
Gastroenterol Hepatol. 26:558–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu H, Shi BM, Lu XF, Liang F, Jin X, Wu TH
and Xu J: Vascular endothelial growth factor attenuates hepatic
sinusoidal capillarization in thioacetamide-induced cirrhotic rats.
World J Gastroenterol. 14:2349–2357. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fernández M, Semela D, Bruix J, Colle I,
Pinzani M and Bosch J: Angiogenesis in liver disease. J Hepatol.
50:604–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Coulon S, Heindryckx F, Geerts A, Van
Steenkiste C, Colle I and Van Vlierberghe H: Angiogenesis in
chronic liver disease and its complications. Liver Int. 31:146–162.
2011. View Article : Google Scholar
|
|
14
|
Thabut D and Shah V: Intrahepatic
angiogenesis and sinusoidal remodeling in chronic liver disease:
New targets for the treatment of portal hypertension? J Hepatol.
53:976–980. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mejias M, Garcia-Pras E, Tiani C, Miquel
R, Bosch J and Fernandez M: Beneficial effects of sorafenib on
splanchnic, intrahepatic and portocollateral circulations in portal
hypertensive and cirrhotic rats. Hepatology. 49:1245–1256. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Majumder S, Piguet AC, Dufour JF and
Chatterjee S: Study of the cellular mechanism of Sunitinib mediated
inactivation of activated hepatic stellate cells and its
implications in angiogenesis. Eur J Pharmacol. 705:86–95. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thabut D, Routray C, Lomberk G, Shergill
U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A,
et al: Complementary vascular and matrix regulatory pathways
underlie the beneficial mechanism of action of sorafenib in liver
fibrosis. Hepatology. 54:573–585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling-in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koch S and Claesson-Welsh L: Signal
transduction by vascular endothelial growth factor receptors. Cold
Spring Harb Perspect Med. 2:a0065022012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koch S, Tugues S, Li X, Gualandi L and
Claesson-Welsh L: Signal transduction by vascular endothelial
growth factor receptors. Biochem J. 437:169–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Finley SD, Dhar M and Popel AS:
Compartment model predicts VEGF secretion and investigates the
effects of VEGF trap in tumor-bearing mice. Front Oncol. 3:1962013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka
Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Yamazaki M,
Tsujinoue H, Imazu H, et al: Vascular endothelial growth factor and
receptor interaction is a prerequisite for murine hepatic
fibrogenesis. Gut. 52:1347–1354. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moreau R: VEGF-induced angiogenesis drives
collateral circulation in portal hypertension. J Hepatol. 43:6–8.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vanheule E, Geerts AM, Van Huysse J,
Schelfhout D, Praet M, Van Vlierberghe H, De Vos M and Colle I: An
intravital microscopic study of the hepatic microcirculation in
cirrhotic mice models: Relationship between fibrosis and
angiogenesis. Int J Exp Pathol. 89:419–432. 2008. View Article : Google Scholar
|
|
25
|
Ankoma-Sey V, Matli M, Chang KB, Lalazar
A, Donner DB, Wong L, Warren RS and Friedman SL: Coordinated
induction of VEGF receptors in mesenchymal cell types during rat
hepatic wound healing. Oncogene. 17:115–121. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coulon S, Heindryckx F, Geerts A, Van
Steenkiste C, Colle I and Van Vlierberghe H: Angiogenesis in
chronic liver disease and its complications. Liver Int. 31:146–162.
2011. View Article : Google Scholar
|
|
27
|
Friedman SL: Preface. Hepatic fibrosis:
Pathogenesis, diagnosis and emerging therapies. Clin Liver Dis.
12:xiii–xiv. 2008. View Article : Google Scholar
|
